About
Ykrita Lifesciences is a medtech startup that has developed the Extracorporeal Bioengineered Dual-Cell Liver Regeneration System (EBDLR System), a portable device designed to support liver function and promote organ self-regeneration in cases of acute liver failure.
Explore Ykrita Lifesciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.